HIGHLIGHTS
- who: H.K. van Halteren from the Department of Medical Oncology, Adrz Hospital, Goes, The NetherlandsOncology, National Cancer Institute of Lithuania, Faculty of Medicine, Vilnius University, Vilnius, Lithuania have published the Article: Twelve ESMO Congress 2022 breakthroughs: practicing oncologists` perceptions and potential application on presented data, in the Journal: (JOURNAL)
- what: The review is structured according to previously proposed potential bias items, which could distort the appraisal of clinical benefit . The ESMO Congress 2022 Abstracts and presentations, as well as the trial information provided at www.clinicaltrials.gov, were used for the reviewing process, which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.